A phase III confirmatory trial of belinostat in combination with cyclophosphamide, vincristine, doxorubicin and prednisone (CHOP) versus CHOP alone in patients with peripheral T-cell lymphoma

Trial Profile

A phase III confirmatory trial of belinostat in combination with cyclophosphamide, vincristine, doxorubicin and prednisone (CHOP) versus CHOP alone in patients with peripheral T-cell lymphoma

Planning
Phase of Trial: Phase III

Latest Information Update: 25 Oct 2016

At a glance

  • Drugs Belinostat (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
  • Indications Peripheral T-cell lymphoma
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 25 Oct 2016 According to an Onxeo media release, this trial is expected to initiate during the end of 2016.
    • 04 Mar 2015 According to Onxeo media release, company is planning to initiate this trial by first quarter of 2016.
    • 30 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top